## XYL: Xylem Inc. - XLI: Industrials

### Executive Summary

No thesis match: MRS_20 -4.7% below STRENGTH zone (4.0-10.0%); PEG 2.12 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($134.17)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 5, Bearish: 0)

**1. XXEC Inc. Purchases 13,404 Shares of Xylem Inc. $XYL**
- Source: MarketBeat | 20251205T133810 | Bullish | Relevance: 100%
- XXEC Inc. has significantly increased its stake in Xylem Inc. by purchasing an additional 13,404 shares, bringing its total holdings to 33,698 shares valued at approximately $4.36 million. This investment now constitutes 3.5% of XXEC's portfolio, making Xylem its 15th largest position. Despite insider selling activity, Xylem reported strong quarterly earnings, beating analyst expectations, and maintains a "Moderate Buy" consensus rating from analysts with a target price of $166.90.

**2. What Does the Market Think About Xylem Inc?**
- Source: Sahm | 20251205T090836 | Neutral | Relevance: 100%
- Xylem Inc.'s short interest has increased by 10.64%, with 2.97 million shares sold short, representing 1.56% of tradable shares. This indicates a growing bearish sentiment among investors, though it doesn't necessarily predict a near-term stock decline. Compared to its peers, Xylem Inc. has less short interest, averaging 4.59%.

**3. M&T Bank Corp Sells 38,381 Shares of Xylem Inc. $XYL**
- Source: MarketBeat | 20251204T131027 | Somewhat-Bullish | Relevance: 100%
- M&T Bank Corp reduced its stake in Xylem Inc. by 24.9% in Q2, selling 38,381 shares and retaining 116,060 shares valued at approximately $15.01 million. Company insiders have also sold 13,121 shares totaling about $1.98 million in the last 90 days. Xylem exceeded quarterly earnings estimates and received a "Moderate Buy" consensus analyst rating with a $166.90 target price.

**4. TD Cowen Adjusts Price Target on Xylem to $135 From $130, Maintains Hold Rating**
- Source: marketscreener.com | 20251205T131509 | Somewhat-Bullish | Relevance: 100%
- TD Cowen has adjusted its price target for Xylem Inc. (NYSE: XYL) to $135 from $130, while maintaining a Hold rating on the stock. This update reflects a modest increase in the target, indicating a continued cautious but not negative outlook for the water technology company. The article also provides a brief overview of Xylem's activities and lists recent analyst ratings and company news.

**5. Xylem Inc. $XYL Shares Bought by Invesco Ltd.**
- Source: MarketBeat | 20251205T122344 | Bullish | Relevance: 100%
- Invesco Ltd. increased its stake in Xylem Inc. (NYSE:XYL) by 4.3% in the second quarter, bringing its total holdings to over 4 million shares valued at $524.69 million. Other institutional investors also significantly bought shares of Xylem, while some insiders sold shares. Analyst ratings for Xylem are predominantly "Buy" or "Hold," with an average target price of $166.90.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 2, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-05 | TD Cowen | $135 | $130 | +4% |
| 2025-11-06 | UBS | $175 | $168 | +4% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-05 | TD Cowen | main | Hold |
| 2025-11-06 | UBS | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 4 ($2.22M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 41.7% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 12.3% (+0.7%)
- Blackrock Inc.: 10.2% (+1.6%)
- State Street Corpora: 4.5% (+1.2%)
- Geode Capital Manage: 2.5% (+1.1%)
- Impax Asset Manageme: 2.2% (-3.3%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 2.12 elevated, pricing in significant growth expectations. Forward P/E 25.0x stretched relative to 10% growth. Insider selling cluster ($2.2M in 90 days), potential headwind. Institutional flow bearish (5 selling vs 5 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $33.8B |
| Beta | 1.17 |
| 52W Range | $100.47 - $154.27 |
| Short Interest | 1.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.12 |
| Forward P/E | 25.0 |
| Current P/E | 27.5 |
| YoY Growth | 9.9% |
| EPS Direction | STABLE |

### Technicals

MRS_20 stable at -4.7% (minimal 5-day change). Below STRENGTH zone by 8.7pp (needs >4.0% for momentum thesis). Underperforming sector by 3.9pp, stock-specific weakness. Long-term uptrend intact (above SMA200 at 1.04x) but short-term weakness (below SMA20). OFD pattern: -MTN (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -4.68% (CS: 13) | Weak |
| RSI_14 | 36.0 | Neutral |
| MACD Histogram | -0.15 | Bearish |
| vs SMA20 | 0.974x | Below |
| vs SMA50 | 0.953x | Below |
| vs SMA200 | 1.045x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $139.01
- **Stop Loss:** $134.17 (3.5% risk)
- **Target:** $143.85 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 247
- **Position Value:** $34,335.47
- **Portfolio %:** 34.34%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | IGNITION (Zone D) | 1.20x |

*NORMAL regime with balanced risk appetite. VIX near 15th percentile of 52-week range signals calm conditions, while modest yield curve steepening (54bps 10Y-3M) suggests healthy growth expectations. Breadth at 52% indicates selective participation rather than broad-based momentum.*

### Earnings

**Next:** 2026-02-03 (Est: $1.41)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.23 | $1.37 | +11.1% |
| 2025Q2 | $1.15 | $1.26 | +9.9% |
| 2025Q1 | $0.95 | $1.03 | +8.0% |
| 2024Q4 | $1.13 | $1.18 | +4.9% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*